Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Approved

Current status date:

2021-02-01

Product name:

LIBRELA

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02511797

Product Monograph/Veterinary Labelling:

Date: 2021-02-01 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

ZOETIS CANADA INC
16740 Trans Canada Highway
Kirkland
Quebec
Canada  H9H 4M7

Class: 

Veterinary

Species:

Dogs

Dosage form(s):

Solution

Route(s) of administration:

Subcutaneous

Number of active ingredient(s):

1

Schedule(s):

Prescription  

American Hospital Formulary Service (AHFS): See footnote 3

Not Applicable

Anatomical Therapeutic Chemical (ATC): See footnote 4

Not Applicable

Active ingredient group (AIG) number:See footnote 5

0162744001

List of active ingredient(s)
Active ingredient(s) Strength
BEDINVETMAB 5 MG / ML

Application information

Related information

Contact us

Version 3.9.1
Date modified: